Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortReserve antibiotic for MRSA, VRE and resistant TB.Hospital antibiotic for MRSA and C. difficile.
Body systemAntibioticsAntibiotics
Drug classOxazolidinonesGlycopeptides
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesMRSA pneumonia and skin infections, Vancomycin-resistant enterococcus (VRE), Drug-resistant tuberculosis (BPaLM regimen)MRSA infections, Sepsis with resistant bacteria, Endocarditis, C. difficile colitis (oral), Meningitis (with other drugs)
How it worksStops bacterial ribosomes forming at all.Grabs the building blocks of the bacterial wall so they can't link up.
Starts working——
Half-life5–7 hours4–6 hours (longer in kidney disease)
Typical adult dose600 mg twice a day (once a day in TB regimens).IV: weight-based, adjusted to blood levels. C. difficile: 125 mg by mouth four times a day for 10 days.
FormsTablet, Oral suspension, IV infusionIV infusion, Capsule, Oral solution
Common side effectsDiarrhoea, Headache, Nausea, Taste changeFlushing and itching if infused too fast, Rash, Nausea
Serious side effectsLow platelets and anaemia (over 2 weeks), Optic and peripheral nerve damage, Serotonin syndrome, Lactic acidosisKidney injury, Hearing damage, Low white cells
Don't take if——
Alcohol——
PregnancyUse with cautionLimited data.Use with cautionUsed when needed; levels monitored.
Breastfeeding——
In use since20001958
Brand namesUnited States: ZyvoxUnited Kingdom: ZyvoxIndia: Linospan, LizolidUnited States: Vancocin, FirvanqUnited Kingdom: Vancocin
Legal status——
ATC codeJ01XX08J01XA01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker